跳至主要内容
临床试验/CTRI/2021/07/034986
CTRI/2021/07/034986尚未招募3 期

A Single blind, randomized, parallel group study to compare efficacy and safety of coded Unani formulation UNIM D 2000 with Metformin in patients with Ziabetus Sukkari Qism-e-Sani (Diabetes Mellitus Type II)

Central Council for Research in Unani Medicine CCRUM0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either gender in the age group of 18-65 years
  • 2.HbA1c level >= 7%
  • 3.Both newly diagnosed and known case of Type 2 DM may be included
  • 4.Fasting plasma glucose levels between 126 and 200 mg/dl
  • 5.2hr plasma glucose levels between 200 and 300 mg/dl
  • 6.Presence of any of the following symptoms and signs of diabetes mellitus:
  • Utash mufrit (Polydipsia)
  • Kasrat al-Bawl (Polyuria)
  • Kasrat al-Ishtiha (Polyphagia)
  • Bawl Layli (Nocturia)
  • Iya (Fatigue)
  • Naqs al-Wazn (Loss of Weight)
  • Burning sensation in palm and soles
  • Sadr (Giddiness)
  • Naqs al-Shahwa (Loss of Libido)
  • Duf al Hadm
  • Bawl-e-raqueeque (lighter urine) with Kasrat
  • Bawl-e-sufed (colourless urine) with Kasrat

排除标准

  • 1.HbA1C >= 8%
  • 2.Subjects with fasting plasma glucose level >200 mg/dl and /or PP plasma glucose level >300 mg/dl
  • 3.Family history of Type 1 DM
  • 4.Known cases of Metabolic syndrome
  • 5.Diabetes Mellitus-Type 1 or subjects on Insulin therapy
  • 6.Diabetes Mellitus associated with complications of Ketoacidosis
  • 7.Patients on systemic corticosteroids/ disease modifying agents
  • 8.Known cases of Ischemic Heart Disease/ Hyperlipidemia
  • 9.Liver disorders SGPT >105 IU/L
  • 10.Impaired renal function tests
  • 11.Obese Subjects â?? BMI >35
  • 12.Pregnant and lactating women
  • 13.Known cases of Malignancy & Epilepsy
  • 14.Known cases of any disorder requiring long-term treatment

研究者

发起方
Central Council for Research in Unani Medicine CCRUM

相似试验